Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ).
Shandong Xinhua Pharmaceutical Company Limited has announced a board meeting scheduled for April 28, 2025, to consider and approve the unaudited results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and related services.
YTD Price Performance: -7.75%
Average Trading Volume: 2,131,863
Technical Sentiment Signal: Hold
Current Market Cap: HK$8.24B
See more data about 0719 stock on TipRanks’ Stock Analysis page.